Halozyme Therapeutics shares owned by Virtus ETF Advisers
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Virtus ETF Advisers
from 13F filings
Historical chart of Virtus ETF Advisers investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Virtus ETF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $393k | 9.7k | 40.68 |
| 2023-12-31 | $306k | 8.3k | 36.96 |
| 2023-09-30 | $353k | 9.2k | 38.20 |
| 2023-06-30 | $376k | 10k | 36.07 |
| 2023-03-31 | $201k | 5.3k | 38.19 |
| 2022-12-31 | $294k | 5.2k | 56.90 |
| 2022-09-30 | $214k | 5.4k | 39.63 |
| 2022-06-30 | $234k | 5.3k | 43.95 |
| 2022-03-31 | $428k | 11k | 39.86 |
| 2021-12-31 | $432k | 11k | 40.23 |
| 2021-09-30 | $429k | 11k | 40.66 |
| 2021-06-30 | $523k | 12k | 45.42 |
| 2021-03-31 | $623k | 15k | 41.66 |
| 2020-12-31 | $621k | 15k | 42.70 |
| 2020-09-30 | $673k | 26k | 26.28 |
| 2020-06-30 | $629k | 24k | 26.82 |
| 2020-03-31 | $558k | 31k | 18.00 |
| 2019-12-31 | $596k | 34k | 17.73 |
| 2019-09-30 | $683k | 44k | 15.51 |
| 2019-06-30 | $884k | 52k | 17.18 |
| 2019-03-31 | $818k | 51k | 16.09 |
| 2018-12-31 | $584k | 40k | 14.62 |
| 2018-09-30 | $749k | 41k | 18.18 |
| 2018-06-30 | $648k | 38k | 16.86 |
| 2018-03-31 | $898k | 46k | 19.60 |
| 2017-12-31 | $981k | 48k | 20.27 |
| 2017-09-30 | $1.4M | 78k | 17.37 |
| 2017-06-30 | $1.0M | 78k | 12.81 |
| 2017-03-31 | $1.2M | 94k | 12.96 |
| 2016-12-31 | $842k | 85k | 9.88 |
| 2016-09-30 | $847k | 70k | 12.08 |
| 2016-06-30 | $529k | 61k | 8.63 |
| 2016-03-31 | $348k | 37k | 9.48 |